Compare NBTX & WMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | WMK |
|---|---|---|
| Founded | 2003 | 1912 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2018 | 1994 |
| Metric | NBTX | WMK |
|---|---|---|
| Price | $37.81 | $79.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 67.4K | ★ 168.4K |
| Earning Date | 03-31-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 1.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.13 |
| Revenue | N/A | ★ $4,714,573,000.00 |
| Revenue This Year | $58.17 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $70.63 |
| Revenue Growth | N/A | ★ 0.01 |
| 52 Week Low | $4.79 | $59.99 |
| 52 Week High | $57.14 | $83.74 |
| Indicator | NBTX | WMK |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 56.42 |
| Support Level | $30.15 | $67.58 |
| Resistance Level | $38.29 | $82.66 |
| Average True Range (ATR) | 2.46 | 2.40 |
| MACD | 0.45 | -0.26 |
| Stochastic Oscillator | 67.69 | 47.68 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.